24 reports

  • Musculoskeletal Drugs was the largest segment in the region market at 15.5% of the market worth about $6.4 billion.

Drugs For Respiratory Diseases P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A

  • Dermatological Treatment
  • Respiratory Monitoring
  • World
  • Market Size
  • Pfizer Inc.

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Dermatological Treatment
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • ORPHAN AND RARE DERMATOLOGY DRUGS MARKET, GLOBAL, APPROVED ORPHAN AND
  • 3.3 Highly Genericized Drugs

Stomach tests involve endoscopies (a popular technique to visualize internal body cavities) and gastrointestinal biopsies (taking a sample from inside the patient' s gastrointestinal tract for analysis).

  • Dermatological Treatment
  • World
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation

Scope of Business: ##.

  • Dermatological Treatment
  • China
  • Demand
  • Trade
  • Xian-Janssen Pharmaceutical Ltd.

Scope of Business: ##.

  • Dermatological Treatment
  • China
  • Ltd Shandong Qilu Pharmacy Co.
  • Novartis AG
  • Xian-Janssen Pharmaceutical Ltd.

Systemic tetracycline may cause gastrointestinal upset, nausea, diarrhea, and vaginal yeast infection.

  • Dermatological Treatment
  • Allergan plc
  • Galderma S.A.
  • Pfizer Inc.
  • Valeant Pharmaceuticals International, Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation

B-## Table of Contents iv U. S.

  • Dermatological Treatment
  • United States
  • ConvaTec Inc.
  • Covidien plc
  • Smith & Nephew Plc
  • PIPELINE BY EA PHARMA CO LTD, H2 2018
  • INTRODUCTION

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Dermatological Treatment
  • Pharmaceutical
  • World
  • Product Initiative
  • Gilead Sciences, Inc.

One unit is one oximeter sensor.

  • Respiratory Monitoring
  • Sensor
  • United States
  • Company
  • GlobalData's company

The company' s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream.

  • Dermatological Treatment
  • Israel
  • United States
  • Company
  • Perrigo Company

The company' s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream.

  • Dermatological Treatment
  • Israel
  • United States
  • Company
  • Perrigo Company

ONE UNIT REFERS TO ONE PEAK FLOW METER.

  • Respiratory Monitoring
  • Germany
  • Southern Europe
  • Western Europe
  • Medtronic, Inc.
  • Respiratory Measurement Devices Companies and Product Overview

One unit is one Capnograph.

  • Clinical Trial
  • Drug Discovery And Development
  • Hospital
  • Respiratory Monitoring
  • Sensor

NO CARDIOVASCULAR-RELATED OR GASTROINTESTINAL RELATED ADVERSE REACTIONS WERE REPORTEDPOSITIVE TOP-LINE DATA FROM U. S.

  • Dermatological Treatment
  • Hospital
  • Respiratory Monitoring
  • Northern Europe
  • United Kingdom
  • Pipeline by EA Pharma Co Ltd, H1 2018
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

Results from the Phase I study were presented at the 2017 Gastrointestinal Cancers Symposium.

  • Dermatological Treatment
  • Hospital
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

The molecules developed by companies in Phase I, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Dermatological Treatment
  • Hospital
  • Therapy
  • World
  • Product Initiative
  • PRASCO LABS ENTERS INTO CO-MARKETING AGREEMENT WITH SHIRE FOR CARBATROL

Prasco LLC, Deals By Therapy Area, 2012 to YTD 2018 Therapy Area Infectious Disease Cardiovascular Central Nervous System Dermatology Gastrointestinal Immunology Musculoskeletal Nutritional Disorders Oncology Respiratory Women' s Health No. of Deals ## ## ## ## ##

  • Dermatological Treatment
  • Healthcare
  • Pharmaceutical
  • United States
  • Prasco, LLC

Parion Sciences develops ENaC blockers which are used to treat lung, mouth, nose and the gastrointestinal tract.

  • Clinical Trial
  • Dermatological Treatment
  • Respiratory Monitoring
  • Therapy
  • United States

The molecules developed by Companies in Phase I, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Dermatological Treatment
  • Therapy
  • World
  • Product Initiative
  • Pfizer Inc.

ONE UNIT REFERS TO ONE CSE KIT.

  • Dermatological Treatment
  • Respiratory Device
  • Respiratory Monitoring
  • North America
  • United States

Another variant of Passover humidifiers is the wick one.

  • Medical Ventilator
  • Respiratory Monitoring
  • World
  • Forecast
  • Teleflex Incorporated

One unit is one Capnograph.

  • Clinical Trial
  • Oxygen Device
  • Respiratory Monitoring
  • United States
  • Masimo Corporation